Qi You - Publications

Identification of a Cuproptosis-Related Molecular Signature for Predicting Biochemical Recurrence in Prostate Cancer.

Journal: Combinatorial chemistry & high throughput screening

Published: June 28, 2025

Comprehensive Analysis Identifies Tumor Mutation Burden-associated Genes ASPM and KIF11 as Novel Biomarkers for Adrenocortical Carcinoma.

Journal: Current cancer drug targets

Published: March 04, 2025

Identification of Selected Genes Associated With the Prediction of Prognosis in Bladder Cancer.

Journal: Combinatorial chemistry & high throughput screening

Published: October 13, 2024

Liquid-liquid phase separation-related genes associated with prognosis, tumor microenvironment characteristics, and tumor cell features in bladder cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 31, 2024

Machine learning-based autophagy-related prognostic signature for personalized risk stratification and therapeutic approaches in bladder cancer.

Journal: International immunopharmacology

Published: January 31, 2024

ND630 controls ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003.

Journal: Journal of translational medicine

Published: March 21, 2023

A tumor-associated macrophages related model for predicting biochemical recurrence and tumor immune environment in prostate cancer.

Journal: Genomics

Published: February 04, 2023

A Liquid-Liquid Phase Separation-Related Index Associate with Biochemical Recurrence and Tumor Immune Environment of Prostate Cancer Patients.

Journal: International journal of molecular sciences

Published: December 04, 2022

Body composition parameters were associated with response to abiraterone acetate and prognosis in patients with metastatic castration-resistant prostate cancer.

Journal: Cancer medicine

Published: September 05, 2022

Head-to-head comparisons of [68Ga]Ga-PSMA-11 PET/CT, multiparametric MRI, and prostate-specific antigen for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer patients: a prospective study.

Journal: European journal of nuclear medicine and molecular imaging

Published: August 18, 2022

Low TLR and PSMA-TV predict biochemical response to abiraterone acetate in metastatic prostate cancer patients developing castration resistance after chemohormonal therapy at hormone-sensitive stage.

Journal: Journal of cancer research and clinical oncology

Published: August 06, 2022

A radiation resistance related index for biochemical recurrence and tumor immune environment in prostate cancer patients.

Journal: Computers in biology and medicine

Published: February 28, 2022